z-logo
open-access-imgOpen Access
Enzalutamide for Primary Immune Prostate Cancer in Routine Clinical Practice: Results from a Rare Metastasis Study in Japan
Author(s) -
Kento Tomohisa,
Toma Abe
Publication year - 2022
Publication title -
journal of clinical case studies reviews and reports
Language(s) - English
Resource type - Journals
ISSN - 2634-680X
DOI - 10.47363/jccsr/2022(4)231
Subject(s) - romiplostim , medicine , enzalutamide , adverse effect , prostate cancer , observational study , platelet , post hoc analysis , oncology , thrombopoietin , cancer , genetics , androgen receptor , stem cell , haematopoiesis , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here